论文部分内容阅读
目的:探讨盐酸氨溴索在临床治疗小儿支气管肺炎的疗效。方法:将本院近半年间接治的90例小儿支气管肺炎患者随机分为对照组及观察组,每组45例。对照组常规抗炎、支持治疗;观察组在上述治疗的基础上加用盐酸氨溴索静脉注射,观察两组的治疗效果情况。结果:观察组与对照组相比在显效率及总有效率上占有明显优势(P<0.05)。并且在肺啰音消失时间及胸部X片恢复正常的时间比较上,观察组与对照组相比也有明显优势(P<0.05)。结论:盐酸氨溴索辅助抗炎药物对小儿支气管肺炎治疗效果显著,可以临床推广。
Objective: To investigate the efficacy of ambroxol hydrochloride in the treatment of bronchial pneumonia in children. Methods: Ninety children with bronchopneumonia treated in our hospital for nearly six months were randomly divided into control group and observation group, with 45 cases in each group. Control group conventional anti-inflammatory, supportive treatment; observation group based on the above treatment plus intravenous ambroxol hydrochloride, the two groups observed the effect of treatment. Results: Compared with the control group, the observation group had obvious advantages in the markedly effective rate and total effective rate (P <0.05). And in the time when the pulmonary rales disappeared and chest X-ray recovery time comparison, the observation group and the control group also had obvious advantages (P <0.05). Conclusion: Ambroxol hydrochloride-assisted anti-inflammatory drugs have a significant therapeutic effect on bronchial pneumonia in children and can be clinically promoted.